KCTD12
BTB/POZ domain-containing protein KCTD12
Also known as: C13orf2, KCD12_HUMAN, KIAA1778, PFET1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96CX2
- Gene
- KCTD12
- Ensembl
- ENSG00000178695
- Chromosome
- 13
- Canonical length
- 325 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Enables identical protein binding activity. Predicted to be involved in regulation of G protein-coupled receptor signaling pathway. Predicted to be located in cell projection; plasma membrane; and synapse. Predicted to be part of receptor complex. Predicted to be active in GABA-ergic synapse; postsynaptic membrane; and presynaptic active zone membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
325 residues, UniProt reviewed canonical sequence.
>Q96CX2|KCTD12
1 MALADSTRGL PNGGGGGGGS GSSSSSAEPP LFPDIVELNV GGQVYVTRRC TVVSVPDSLL
61 WRMFTQQQPQ ELARDSKGRF FLDRDGFLFR YILDYLRDLQ LVLPDYFPER SRLQREAEYF
121 ELPELVRRLG APQQPGPGPP PSRRGVHKEG SLGDELLPLG YSEPEQQEGA SAGAPSPTLE
181 LASRSPSGGA AGPLLTPSQS LDGSRRSGYI TIGYRGSYTI GRDAQADAKF RRVARITVCG
241 KTSLAKEVFG DTLNESRDPD RPPERYTSRY YLKFNFLEQA FDKLSESGFH MVACSSTGTC
301 AFASSTDQSE DKIWTSYTEY VFCRELocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCTD12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- placenta: 79 nTPM
- adipose tissue: 71 nTPM
- fallopian tube: 71 nTPM
- ovary: 67 nTPM
- spleen: 61 nTPM
- smooth muscle: 61 nTPM
Single-cell type
- kupffer cells: 524 nCPM
- neuroendocrine cells: 406 nCPM
- monocytes: 393 nCPM
- hofbauer cells: 384 nCPM
- macrophages: 301 nCPM
- vascular endothelial cells: 284 nCPM
Immune cell
- classical monocyte: 3.9 nTPM
- myeloid DC: 3.7 nTPM
- intermediate monocyte: 2.5 nTPM
- plasmacytoid DC: 1.9 nTPM
- non-classical monocyte: 1.5 nTPM
- neutrophil: 1 nTPM
Brain region
- spinal cord: 86 nTPM
- medulla oblongata: 83 nTPM
- white matter: 79 nTPM
- midbrain: 77 nTPM
- pons: 73 nTPM
- thalamus: 73 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Potassium channel tetramerisation-type BTB domain
- SKP1/BTB/POZ domain superfamily
- KCTD8/12/16, H1 domain
- BTB/POZ domain
- KCTD8/12/16 H1 domain
- Potassium channel tetramerization domain-containing protein 12, H1 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCTD12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCTD12 as an antibody target. Whether an autoantibody or antibody against KCTD12 could matter depends on whether native KCTD12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCTD12 is annotated at the cell surface, where native KCTD12 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCTD12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...